Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 2Uterine Cervical Neoplasms 1Stomatitis 1Neoplasms 1Melanoma 1Lymphedema 1Disease 1

Interventions

fluciclovine F-18 2Positron-Emission Tomography 2Injections 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2pembrolizumab 1ioflupane 1idelalisib 1aflibercept 1Water 1Vertical Dimension 1Methylene Blue 1Mammography 1Drug Delivery Systems 1Diagnosis, Computer-Assisted 1Daunorubicin 1Cytarabine 1Control Groups 1CPX-351 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Disease × Methylene Blue × Clear all
NCT00784849 2012-06-20

Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)

Louisiana State University Health Sciences Center in New Orleans

Phase 2 Completed
62 enrolled 5 charts
Breast

Breast Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡